|
|
|
Volumn 2, Issue 2, 2002, Pages 89-94
|
|
The controversy over estrogen replacement therapy: an update on clinical trials.
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ESTROGEN;
GESTAGEN;
RALOXIFENE;
SELECTIVE ESTROGEN RECEPTOR MODULATOR;
AGED;
BREAST TUMOR;
CARDIOVASCULAR DISEASE;
CLINICAL TRIAL;
ESTROGEN THERAPY;
FEMALE;
HUMAN;
METHODOLOGY;
MIDDLE AGED;
REVIEW;
RISK FACTOR;
AGED;
BREAST NEOPLASMS;
CARDIOVASCULAR DISEASES;
CLINICAL TRIALS;
ESTROGEN REPLACEMENT THERAPY;
ESTROGENS;
FEMALE;
HUMANS;
MIDDLE AGED;
PROGESTINS;
RALOXIFENE;
RISK FACTORS;
SELECTIVE ESTROGEN RECEPTOR MODULATORS;
|
|
EID: 0036528534
PISSN: 15345874
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (3)
|
|
References (31)
|
